S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
OTCMKTS:BTCS

BTCS (BTCS) Stock Price, News & Analysis

$1.42
-0.03 (-2.07%)
(As of 04/19/2024 08:50 PM ET)
Today's Range
$1.40
$1.45
50-Day Range
$1.22
$1.83
52-Week Range
$0.85
$2.50
Volume
32,500 shs
Average Volume
234,876 shs
Market Capitalization
$22.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

BTCS MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
111.3% Upside
$3.00 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.33) to ($0.31) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.86 out of 5 stars

BTCS stock logo

About BTCS Stock (OTCMKTS:BTCS)

BTCS Inc. focuses on blockchain infrastructure and staking in the United States. The company secures blockchain-infrastructure operations and operates validator nodes on disruptive next-generation blockchain networks. It offers StakeSeeker, a cryptocurrency dashboard and staking-as-a-service platform that allows crypto asset holders to earn rewards by participating in network consensus mechanisms. The company was formerly known as Bitcoin Shop, Inc. and changed its name to BTCS Inc. in July 2015. BTCS Inc. was founded in 2014 and is based in Silver Spring, Maryland.

BTCS Stock Price History

BTCS Stock News Headlines

Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
BTCS Inc.
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
Stone Castle renovation begins in Bristol
BTCS Inc BTCS
See More Headlines
Receive BTCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BTCS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/21/2024
Today
4/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Capital Markets
Sub-Industry
N/A
Current Symbol
OTCMKTS:BTCS
Fax
N/A
Employees
5
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.00
High Stock Price Target
$3.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+111.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-15,890,000.00
Net Margins
-370.07%
Pretax Margin
-369.99%

Debt

Sales & Book Value

Annual Sales
$1.34 million
Book Value
$0.42 per share

Miscellaneous

Free Float
8,571,000
Market Cap
$22.28 million
Optionable
Not Optionable
Beta
1.58
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives


BTCS Stock Analysis - Frequently Asked Questions

Should I buy or sell BTCS stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BTCS in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BTCS shares.
View BTCS analyst ratings
or view top-rated stocks.

What is BTCS's stock price target for 2024?

1 Wall Street research analysts have issued 1 year price targets for BTCS's shares. Their BTCS share price targets range from $3.00 to $3.00. On average, they expect the company's share price to reach $3.00 in the next twelve months. This suggests a possible upside of 111.3% from the stock's current price.
View analysts price targets for BTCS
or view top-rated stocks among Wall Street analysts.

How have BTCS shares performed in 2024?

BTCS's stock was trading at $1.63 at the beginning of 2024. Since then, BTCS shares have decreased by 12.9% and is now trading at $1.42.
View the best growth stocks for 2024 here
.

How were BTCS's earnings last quarter?

BTCS Inc. (OTCMKTS:BTCS) released its quarterly earnings results on Thursday, March, 21st. The company reported ($0.09) EPS for the quarter, meeting the consensus estimate of ($0.09). The company had revenue of $0.33 million for the quarter. BTCS had a negative net margin of 370.07% and a negative trailing twelve-month return on equity of 43.20%.

Is BTCS a good dividend stock?

BTCS (OTCMKTS:BTCS) pays an annual dividend of $0.05 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 8.93%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for BTCS.

When did BTCS's stock split?

BTCS's stock split on the morning of Thursday, May 11th 2023. The 2-1 split was announced on Thursday, May 11th 2023. The newly created shares were distributed to shareholders after the market closes on Thursday, May 11th 2023. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What other stocks do shareholders of BTCS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BTCS investors own include Cerus (CERS), Medical Marijuana (MJNA), MGT Capital Investments (MGTI), Mitek Systems (MITK), Materion (MTRN), SCYNEXIS (SCYX), Energous (WATT), Advanced Micro Devices (AMD) and Carnival Co. & (CCL).

How do I buy shares of BTCS?

Shares of BTCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BTCS) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners